The news comes as India, the world's biggest vaccine maker, is being criticised domestically for donating or selling more doses than inocul...

As things stand, it's either AstraZeneca or nothing for some poorer countries. The vaccine from the Anglo-Swedish drug maker is cheaper and...

The World Health Organization, AstraZeneca, and the European Medicines Agency have insisted the shot is safe, and that there is no link bet...

The AstraZeneca vaccine is already being administered in Brazil, but is registered only for emergency use, and the doses have been imported...

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...

With efficacy of just over 50% - barely above Brazil's threshold for regulatory approval - the Chinese shot was not the government's first ...

SII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make u...

Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India (SII), will a...

The jab would be the third available for the 27-nation European Union after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to...

Vaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and eff...

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said the volunteer was Brazi...

The Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India, Reuters re...

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...

AstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.

The deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading...

India's largest BPO firm Genpact Limited on Monday announced the opening of its operations in Brazil, its first location in South America.

BPO major Genpact on Monday said it has opened a new centre in Brazil, its first location in South America.